Why retesting matters more than testing.
A single lab is a snapshot. Physiology is a trend. How often we retest, what we look for in the space between draws, and why the second measurement is usually worth more than the first.
The first panel gets all the attention. It is the one people are nervous about, the one that gets discussed at length, the one that feels like the answer.
It is the least informative panel you will ever have.
Not because it is wrong, but because a single measurement of a fluctuating quantity, read against a range describing other people, can only tell you so much. The second measurement is where the information starts.
One point cannot show a direction
Reference ranges are wide — often wide enough that a marker can double while remaining inside them from beginning to end.
Take a fasting insulin that has climbed steadily over four years, never once leaving the range. Every report said normal. Every report was accurate. The trajectory is the finding, and no single draw contains it.
This is the argument for keeping results rather than filing them. Your own previous values are a better reference range than the population's, because they control for the one variable a population range cannot: you.
The population range tells you how you compare to other people. Your own history tells you what is actually happening.
Biological and analytical variation
Two kinds of noise sit underneath every result, and understanding them prevents a lot of unnecessary alarm.
Biological variation is genuine fluctuation in you. Testosterone follows a daily rhythm and varies day to day. Cortisol changes hour to hour. hsCRP rises with any minor infection. Ferritin climbs with inflammation. Lipids shift with recent alcohol, illness, or weight change.
Analytical variation is the assay's own imprecision, plus real differences between laboratories and methods. The same sample split between two labs can return meaningfully different numbers on some markers.
Together, these mean that a modest change between two draws may represent nothing at all. There is a concept for this — the reference change value, the difference required before a change is likely to be real rather than noise — and for some markers that threshold is surprisingly large.
Which produces two practical rules. A single surprising result is a reason to repeat the test before acting on it. And where possible, retest at the same laboratory, at the same time of day, under similar conditions — because otherwise you are measuring the circumstances rather than the person.
When we retest
It depends on the marker and on why we are looking.
Some things move quickly. After a change in iron status, a meaningful shift in ferritin can be visible within weeks. Inflammatory markers respond over weeks. Some things are deliberately slow: HbA1c reflects roughly three months of glucose exposure, so retesting it at six weeks tells you about a period that was half over before the change began.
Thyroid changes need around six weeks to reach a new steady state after any adjustment. Lipids after a meaningful intervention are generally reviewed after several weeks. And some markers barely need repeating at all — Lp(a) is largely genetic and stable, and once is usually enough for a lifetime.
The general shape is: an early check to confirm direction, a later one to confirm it held, then a settled interval. Testing more often than the marker can meaningfully move produces noise, cost and worry without information.
What happens between draws
The interval is not empty. It is where most of the actual information lives.
We are interested in whether sleep changed, whether energy has a different shape through the day, whether training tolerance moved, how mood and concentration have gone, whether anything got worse. Symptoms are data. They are noisier than a lab value and they are also the reason anyone came in.
Where the two disagree, that disagreement is itself useful. Markers improved and the person feels no different — something else is going on, and we have not found it yet. The person feels considerably better and the markers barely moved — worth understanding why before assuming the protocol deserves the credit.
The uncomfortable part
Retesting is also how you find out something did not work.
That is not a comfortable feature, and it is the main reason it gets skipped. A protocol that is never re-measured can continue indefinitely on the strength of feeling somewhat better — which is genuinely confounded by season, sleep, expectation, regression to the mean, and the substantial effect of being taken seriously by someone.
I would rather know at three months than at three years. Stopping something that is not working is as much a clinical decision as starting it, and it is only available to people who measured.
This is also the sharpest distinction between a protocol and a subscription. A protocol has review points and exit criteria. A subscription has a renewal date.
So: the first panel maps the territory. The second tells you whether you are moving, and in which direction. If you only ever do one, you have a photograph of a place you were passing through.
Measure, treat, and then measure again.
A first consultation runs seventy-five minutes and includes a comprehensive biomarker map, reviewed with you in plain language.
Book a Consultation→ Learn more →This article is educational and is not medical advice, diagnosis, or treatment. Laboratory results and therapies require interpretation in the context of your history, symptoms, medications, and examination, and what is appropriate differs from person to person. Nothing here should be used to start, stop, or change any treatment. Please speak with a qualified clinician who knows your case.